期刊文献+

亚急性甲状腺炎合并肝功能异常及高血压患者的药学监护 被引量:4

Pharmaceutical care for patient with subacute granulomatous thyroiditis complicated with hepatic dysfunction and hypertension
原文传递
导出
摘要 目的探讨亚急性甲状腺炎合并肝功能异常及高血压患者的规范化药学服务方法及模式。方法本例患者的用药监护主要包括选择无需肝转化的氢化泼尼松注射液抗炎,注意氢化泼尼松的溶媒乙醇所致的过敏及双硫仑反应、调整氨氯地平及普萘洛尔给药时间。结果与结论患者亚急性甲状腺炎症状明显减轻,肝功能好转,血压控制正常,未发生药物不良反应。 Objective To explore the standardization of pharmaceutical care methods and patterns used for the patient with subacute granuloma-tous thyroiditis complicated with hepatic dysfunction and hypertension. Methods Pharmaceutical care provided for this patient included selec-ting active hydroprednisone without hepatic metabolism, paying more attention to hydroprednisone-induced anaphylaxis and disulfiram reac-tion, and adjusting administration time of amlodipine and propranolol. Results and Conclusion Symptoms of this patient with subacute granu-lomatous thyroiditis and hepatic dysfunction were alleviated, blood pressure reduced significantly, and adverse drug reactions did not occurre by pharmaceutical care mentioned above.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第21期2156-2157,共2页 The Chinese Journal of Clinical Pharmacology
基金 江苏省国际交流支撑计划基金资助项目(JSH-2011-018)
关键词 药学监护 亚急性甲状腺炎 肝功能不良 高血压 合理用药 pharmaceutical care subacute granulomatous thyroiditis hepatic dysfunction hypertension rational use of drug
  • 相关文献

参考文献4

二级参考文献13

  • 1乐文.BI公司的美洛昔康接近上市[J].国外药讯,1995,11:16-17. 被引量:2
  • 2孙定人 张石革 等.国家临床新药集[M].北京:中国医药科技出版社,2000.526-529. 被引量:5
  • 3陈望忠.两种新的选择性环氧合酶-2抑制剂[J].国外医学(药学分册),1997,24(3):168-171. 被引量:38
  • 4J.R Vane.Nature New Biol[M],1971,231:232~233 被引量:1
  • 5Famaey JP.In vitro and vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide:an overview[J].Inflamm Res,1997,46(11):437 被引量:1
  • 6Tavares IA, Bishai PM ,Bennett A. Activity of nimesulide on constitutive and inducible cyclooxygenases Arzneimittelforsch[J],1995;45(10):1093 被引量:1
  • 7Reiner M.. Jorunal of International Medical research[J],1982;10:92 被引量:1
  • 8Rabasseda X. Drugs of Today[J].1996,32(suppl o),1 被引量:1
  • 9J.Schmid, et al.Xenobiotica[J],1995;11(25):1219 被引量:1
  • 10Distel M, Mueller C, Bluhmki E,et.al. Safety of meloxicam:a global analysis ofClinical trials[J].Br J Rheumatol,1996;35(suppl I):68 被引量:1

共引文献13

同被引文献28

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部